650
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Novel organogels for topical delivery of naproxen: design, physicochemical characteristics and in vitro drug permeation

, , , , , & show all
Pages 521-536 | Received 30 Oct 2015, Accepted 14 Dec 2015, Published online: 20 Jan 2016

References

  • Laneuville O, Breuer DK, Dewitt DL, et al. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharm Exp Ther 1994;271:927–934.
  • Duggan KC, Walters MJ, Musee J, et al. Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen. J Biol Chem 2010;285:34950–34959.
  • Roberts DN, Miner PB. Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease. Drug Healthc Patient Saf 2011;3:1–8.
  • Lundberg GD. Prednisolone and naproxen both work for pain relief in acute gout. Medscape J Med 2008;10:207
  • Lecomte J, Buyse H, Taymans J, Monti T. Treatment of tendinitis and bursitis: a comparison of nimesulide and naproxen sodium in a double-blind parallel trial. Eur J Rheumatol Inflamm 1994;14:29–32.
  • Martin VT, Ballard J, Diamond MP, et al. Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium. J Womens Health (Larchmt) 2014;23:389–396.
  • Akbulut N, Üstüner E, Atakan C, Çölok G. Comparison of the effect of Naproxen, Etodolac and Diclofenac on postoperative sequelsfollowing third molar surgery: a randomised, double-blind, crossover study. Med Oral Patol Oral Cir Bucal 2014;19:149–156.
  • Lubet RA, Steele VE, Juliana MM, Grubbs CJ. Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy. J Urol 2010;183:1598–1603.
  • González Maglio DH, Paz ML, Ferrari A, et al. Alterations in skin immune response throughout chronic UVB irradiation-skin cancer development and prevention by naproxen. Photochem Photobiol 2010;86:146–152.
  • Tian Q, Ren F, Xu Z, et al. Preparation of high solubilizable microemulsion of naproxen and its solubilization mechanism. Int J Pharm 2012;426:202–210.
  • Aabakken L, Bjørnbeth BA, Hofstad B, et al. Comparison of the gastrointestinal side effects of naproxen formulated as plain tablets, enteric-coated tablets, or enteric-coated granules in capsules. Scand J Gastroenterol Suppl 1989;163:65–73.
  • Kovacevic L, Bernstein J, Valentini RP, et al. Renal papillary necrosis induced by naproxen. Pediatr Nephrol 2003;18:826–829.
  • Victorino RM, Silveira JC, Baptista A, de Moura MC. Jaundice associated with naproxen. Postgrad Med J 1980;56:368–370.
  • Underwood M, Ashby D, Cross P, et al. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ 2008;336:138
  • Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999;31:5–19.
  • Lampe MA, Burlingame AL, Whitney J, et al. Human stratum corneum lipids: characterization and regional variations. J Lipid Res 1983;24:120–130.
  • Trommer H, Neubert RHH. Overcoming the stratum corneum: the modulation of skin penetration. Skin Pharmacol Physiol 2006;19:106–121.
  • Stoughton RB. Percutaneous absorption of drugs. Ann Rev Pharmacol Toxicol 1989;29:55–69.
  • Nagelreiter C, Raffeiner S, Geyerhofer C, et al. Influence of drug content, type of semi-solid vehicle and rheological properties on the skin penetration of the model drug fludrocortisone acetate. Int J Pharm 2013;448:305–312.
  • Suh H, Jun HW, Dzimianski MT, Lu GW. Pharmacokinetic and local tissue disposition studies of naproxen-following topical and systemic administration in dogs and rats. Biopharm Drug Dispos 1997;18:623–633.
  • Flynn GL, Stewart B. Percutaneous drug penetration: choosing candidates for transdermal development. Drug Dev Res 1988;13:169–185.
  • Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56:604–607.
  • Ma X, Fang L, Guo J, et al. Effect of counter-ions and penetration enhancers on the skin permeation of flurbiprofen. J Pharm Sci 2010;99:1826–1837.
  • Hadgraft J, Peck J, Williams DG, et al. Mechanisms of action of skin penetration enhancers/retarders: azone and analogues. Int J Pharm 1996;141:17–25.
  • Degim T, Uslu A, Hadgraft J, et al. The effects of azone and capsaicin on the permeation of naproxen through human skin. Int J Pharm 1999;179:21–25.
  • Lane ME. Skin penetration enhancers. Int J Pharm 2013;447:12–21.
  • Otto A, Wiechers JW, Kelly CL, et al. Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients. Skin Pharmacol Physiol 2008;21:326–334.
  • Squillante E, Needham T, Maniar A, et al. Codiffusion of propylene glycol and dimethyl isosorbide in hairless mouse skin. Eur J Pharm Biopharm 1998;46:265–271.
  • Liu Z, Nie S, Guo H, et al. Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. J Pharm Pharmacol 2005;58:45–50.
  • Ganem-Quintanar A, Lafforgue C, Falson-Rieg F, Buri P. Evaluation of the transepidermal permeation of diethylene glycol monoethyl ether and skin water loss. Int J Pharm 1997;147:165–171.
  • Puglia C, Bonina F, Rizza L, et al. Evaluation of percutaneous absorption of naproxen from different liposomal formulations. J Pharm Sci 2010;99:2819–2829.
  • Szura D, Ozimek Ł, Przybyło M, et al. The impact of liposomes on transdermal permeation of naproxen-in vitro studies. Acta Pol Pharm 2014;71:145–151.
  • Okur NÜ, Apaydın S, Yavaşoğlu NÜK, et al. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations. Int J Pharm 2011;416:136–144.
  • Rajurkar VG, Tambe AB, Deshmukh VK. Topical anti-inflammatory gels of naproxen entrapped in eudragit based microsponge delivery system. J Adv Chem Eng 5:122. DOI: 10.4172/2090-4568.1000122.
  • Tambade SA, Aloorkar NH, Dabane NS, et al. Formulation and Evaluation of Novel Gel Containing Liquid Crystals of Naproxen. AJADD 2014;2:364–386.
  • Dharmalingam SR, Kumarappan CT, Yong MWH, et al. An investigation on the naproxen solubility and permeability enhancement in poly(vinyl alcohol) gel for topical application. International Conference on Medical and Pharmaceutical Sciences (ICMPS’2012); 2012 June 16-17; Bangkok.
  • Barakat NS. Evaluation of glycofurol-based gel as a new vehicle for topical application of naproxen. AAPS PharmSciTech 2010;11:1138–46.
  • Valjakka-Koskela R, Kirjavainen M, Miinkkanen J, et al. Enhancement of percutaneous absorption of naproxen by phospholipids. Int J Pharm 1998;175:225–230.
  • Escobar-Chávez JJ, Quintanar-Guerrero D, Ganem-Quintanar A. In vivo skin permeation of sodium naproxen formulated in Pluronic F-127 gels: effect of azone and transcutol. Drug Dev Ind Pharm 2005;31:447–454.
  • Mura P, Faucci MT, Bettinetti GP. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin. Eur J Pharm Sci 2001;13:187–194.
  • Beetge E, Du Plessis J, Müller DG, et al. The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID's on their transdermal absorption. Int J Pharm 2000;193:261–264.
  • Pacheco DP, Martínez F. Thermodynamic analysis of the solubility of naproxen in ethanol1water cosolvent mixtures. Phys Chem Liq 2007;45:581–595.
  • Nair A, Jacob S, Al-Dhubiab B, et al. Basic considerations in the dermatokinetics of topical formulations. Braz J Pharm Sci 2013;49:423–434.
  • Bonacucina G, Martelli S, Palmieri GF. Rheological, mucoadhesive and release properties of Carbopol gels in hydrophilic cosolvents. Int J Pharm 2004;282:115–130.
  • Malmsten M. Surfactants and polymers in drug delivery. Basel, New York: Marcel Dekker Inc.; 2002
  • Ivanova R, Lindman B, Alexandridis P. Effect of pharmaceutically acceptable glycols on the stability of the liquid crystalline gels formed by Poloxamer 407 in water. J Colloid Interface Sci 2002;252:226–235.
  • Patel HR, Patel RP, Patel MM. Poloxamers: a pharmaceutical excipients with therapeutic behaviors. Int J Pharm Tech Res 2009;1:299–303.
  • Karadzovska D, Riviere JE. Assessing vehicle effects on skin absorption using artificial membrane assays. Eur J Pharm 2013;50:569–576.
  • Uchida T, Kadhum WR, Kanai S, et al. Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M™. Eur J Pharm Sci 2015;67:113–118.
  • Buhse L, Kolinski R, Westenberger B, et al. Topical drug classification. Int J Pharm 2005;295:101–112.
  • Farinha A, Toscano C, Campos R, et al. Permeation of naproxen from saturated solutions and commercial formulations through synthetic membranes. Drug Dev Ind Pharm 2003;29:489–494.
  • StatSoft, Inc. (2011). STATISTICA (data analysis software system), version 10. Available from: www.statsoft.com.
  • Benson HAE. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliver 2005;2:23–33.
  • Song J-S, Sohn Y-T. Crystal forms of naproxen. Arch Pharm Res 2011;34:87–90.
  • Chieng N, Rades T, Aaltonen J. An overview of recent studies on the analysis of pharmaceutical polymorphs. J Pharm Biomed Anal 2011;55:618–644.
  • Chang R-K, Raw A, Lionberger R, Yu L. Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products. AAPS 2013; 15:41–52.
  • Dokic L, Dapcevic T, Krstonosic V, et al. Rheological characterization of corn starch isolated by alkali method. Food Hydrocolloid 2010;24:172–177.
  • Zhu H, Kim YD, Kee DD. Non-Newtonian fluids with a yield stress. J Non-Newtonian Fluid Mech 2005;129:177–181.
  • Hannote M, Flores F, Torres L, Galindo E. Apparent yield stress estimation in xanthan gum solutions and fermentation broths using a low-cost viscometer. Chem Eng J 1991;45:49–56.
  • Meyvis TKL, De Smedt SC, Demeester J, Hennink WE. Rheological monitoring of long-term degrading polymer hydrogels. J Rheol 1999;43:933–950.
  • Meyvis TKL, Stubbe BG, Van Steenbergen MJ, et al. A comparison between the use of dynamic mechanical analysis and oscillatory shear rheometry for the characterisation of hydrogels. Int J Pharm 2002;244:163–168.
  • A-sasutjarit R, Sirivat A, Vayumhasuwan P. Viscoelastic properties of carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases. Pharm Res 2005;22:2134–2140.
  • Chu JS, Yu DM, Amidon GL, et al. Viscoelastic properties of polyacrylic acid gels in mixed solvents. Pharm Res 1992;9:1659–1663.
  • Smith TJ, Kennedy JE, Higginbotham CL. Rheological and thermal characteristics of a two phase hydrogel system for potential wound healing applications. J Mater Sci 2010;45:2884–2891.
  • Heng PWS, Chan LW, Chow KT. Development of novel nonaqueous ethylcellulose gel matrices: rheological and mechanical characterization. Pharm Res 2005;22:676–684.
  • Islam MT, Rodríguez-Hornedo N, Ciotti S, Ackermann C. Rheological characterization of topical carbomer gels neutralized to different pH. Pharm Res 2004;21:1192–1199.
  • Ferguson J, Kemblowski Z. Applied Fluid Rheology. London: Elsevier; 1991.
  • Jones DS, Woolfson AD, Brown AF. Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res 1977;14:450–457.
  • Jones DS, Woolfson AD, Brown AF. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm 1997;151:223–233.
  • Jones DS, Woolfson D, Djokic J. Texture profile analysis of bioadhesive polymeric semisolids: mechanical characterization and investigation of interactions between formulation components. J Appl Polym Sci 1996;61:2229–2234.
  • Gratieri T, Gelfuso GM, Rocha EM, et al. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm 2010;75:186–193.
  • Yilmaz MT, Karaman S, Dogan M, et al. Characterization of O/W model system meat emulsions using shear creep and creep recovery tests based on mechanical simulation models and their correlation with texture profile analysis (TPA) parameters. J Food Eng 2012;108:327–336.
  • The United States Pharmacopoeial Convention. Semisolid drug products-performance tests. USP 36-NF 31: <1724>; 2013.
  • Ng S-F, Rouse JJ, Sanderson FD, et al. Validation of a static franz diffusion cell system for in vitro permeation studies. AAPS PharmSciTech 2010;11:1432–1441.
  • Ng S-F, Rouse J, Sanderson D, Eccleston G. A comparative study of transmembrane diffusion and permeation of ibuprofen across synthetic membranes using Franz diffusion cells. Pharmaceutics 2010;2:209–223.
  • Barry BW. Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev 2002;54:31–40.
  • Welin-Berger K, Neelissen JAM, Bergenstâhl B. The effect of rheological behaviour of a topical anaesthetic formulation on the release and permeation rates of the active compound. Eur J Pharm Sci 2001;13:309–318.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.